Daniel Hal Solomon MD

Professor, Medicine-Brigham & Women's Hospital, Harvard Medical School

111 Cypress StBrookline, MA 02445
Phone+1 857-307-0896
Fax+1 857-307-0899

Dr. Solomon is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Solomon's full profile Already have an account?

Education & Training

Mass General Brigham/Brigham and Women's HospitalFellowship, Rheumatology, 1995 - 1998
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1993 - 1996
Boston University Medical CenterInternship, Internal Medicine, 1992 - 1993
Yale School of MedicineClass of 1992

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 1994 - 2027
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Longitudinal Medical Record, Partners Healthcare System, 2013-2016
CMS Meaningful Use Stage 1 Certification Partners Longitudinal Medical Record, Partners Healthcare System, 2013-2016
CMS Meaningful Use Stage 2 Certification Longitudinal Medical Record, Partners Healthcare System, 2013-2016

Clinical Trials

Patient- and Physician-Based Osteoporosis Education Start of enrollment: 2003 Sep 01
Completed
Phase 1
Improving Management of Patients at High Risk for Osteoporotic Fractures (0000-038) Start of enrollment: 2004 Sep 01
Completed
Not Applicable
Evaluating Ways to Improve Medication Use Among People With Osteoporosis Start of enrollment: 2007 Nov 01
Completed
Phase 3

Publications & Presentations

PubMed

1 citations
Big Data May Have Big Pitfalls: Ensuring Rigor in Rheumatic Disease Epidemiology.
Karen H Costenbader, Daniel H Solomon, S Louis Bridges
Arthritis & Rheumatology. 2026-08-01
Comparison of Rule-Based Algorithms to Identify Patients With Idiopathic Inflammatory Myopathies in Electronic Health Records.
Ana Lucia Valle, Amy Vo, Rochelle L Castillo, Yumeko Kawano, Leah M Santacroce
ACR Open Rheumatology. 2026-07-01
Cystatin C and Creatinine-Based Estimated GFR and Disease Activity Biomarkers in Rheumatoid Arthritis.
Sho Fukui, Lesley A Inker, Leah M Santacroce, Jon T Giles, Katherine P Liao
American Journal of Kidney Diseases. 2026-07-01

Journal Articles

Relationship of Interleukin-1β Blockade with Incident Gout and Serum Uric Acid Levels: Exploratory Analysis of a Randomized Controlled Trial
Daniel H Solomon, Paul M Ridker, Brendan M Everett, Peter Libby, Annals of Internal Medicine
Association Between Inflammation and Systolic Blood Pressure in RA Compared to Patients Without RA
Daniel H Solomon, Katherine P Liao, Seoyoung C Kim, BioMed Central

Other

Nonselective NSAIDs: Overview of adverse effects
Solomon DH
http://www.uptodate.com/contents/nonselective-nsaids-overview-of-adverse-effects
UpToDate, Wolters Kluwer Health - 2012-05-09
NSAIDs: Mechanism of action
Solomon DH
http://www.uptodate.com/contents/nsaids-mechanism-of-action
UpToDate, Wolters Kluwer Health - 2012-04-18
Overview of selective COX-2 inhibitors
Solomon DH
http://www.uptodate.com/contents/overview-of-selective-cox-2-inhibitors
UpToDate, Wolters Kluwer Health - 2012-04-17

Press Mentions

New Editor in Chief Has Expansive Vision for Arthritis & RheumatologyMay 30th, 2025
Precision Medicine on a Population LevelFebruary 6th, 2025
Precision Medicine on a Population Level: Can Digital Health Technology Improve Access to Rheumatologic Care?January 16th, 2025

Grant Support

Treat-to-Target Serum Urate versus Treat-to-Avoid Symptoms in Gout: A Randomized Controlled Trial (TRUST)MASSACHUSETTS GENERAL HOSPITAL2023–2028
VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYticsBRIGHAM AND WOMEN'S HOSPITAL2017–2027
Rheumatoid Arthritis and the Risk of Cardiovascular Disease: Biomarkers Risk Prediction and Underlying MechanismsBRIGHAM AND WOMEN'S HOSPITAL2022–2026
Hydroxychloroquine To Improve Insulin Sensitivity In Rheumatoid ArthritisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2010–2011
Modifiable Disparities In Treatment For Rheumatoid ArthritisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2009–2011